Pacific Biosciences Of California | PACB - Current Liabilities


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

API Features Documentation Interested? Click here to contact us
Please Paste this Code in your Website
width
height
 Preview

Pacific Biosciences Of California

Pacific Biosciences Of California reported $123.11M in Current Liabilities for its fiscal quarter ending in March of 2023.


Current Liabilities Change
Accelerate Diagnostics AXDX:US USD 68.12M 1.57M
Agilent A:US USD 1.67B 270M
Bruker BRKR:US USD 1.05B 137.5M
Danaher DHR:US USD 8.73B 341M
General Electric GE:US USD 48.18B 8.77B
Illumina ILMN:US USD 2.23B 543M
Myriad Genetics MYGN:US USD 143.3M 6.1M
NanoString Technologies NSTG:US USD 57.99M 869K
Pacific Biosciences Of California PACB:US USD 123.11M 140.22M
PerkinElmer PKI:US USD 1.56B 19.26M
Quidel QDEL:US USD 1.09B 84.1M
Roche Holding ROG:VX CHF 27.24B 170M
Standard Biotools Inc FLDM:US USD 43.79M 344K
Thermo Fisher Scientific TMO:US USD 15.88B 1.23B
Waters WAT:US USD 801.95M 16.21M